Authors: Dieras, V Beuzeboc, P Laurence, V Pierga, JY Pouillart, P

Citation: V. Dieras et al., Interaction between Herceptin((R)) and taxanes, ONCOL-BASEL, 61, 2001, pp. 43-49

Authors: Pierga, JY Asselain, B Jouve, M Dieras, V Carton, M Laurence, V Girre, V Beuzeboc, P Palangie, T Dorval, T Pouillart, P

Citation: Jy. Pierga et al., Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy, CANCER, 91(6), 2001, pp. 1079-1089

Authors: Cottu, PH Extra, JM Espie, M Marolleau, J de Roquancourt, A Makke, J Miclea, JM Laurence, V Mayeur, D Lerebours, F Cuvier, C Marty, M

Citation: Ph. Cottu et al., High-dose sequential epirubicin and cyclophosphamide with peripheral bloodstem cell support for advanced breast cancer: results of a phase II study, BR J CANC, 85(9), 2001, pp. 1240-1246

Authors: Pierga, JY Mouret, E Dieras, V Laurence, V Beuzeboc, P Dorval, T Palangie, T Jouve, M Vincent-Salomon, A Scholl, S Extra, JM Asselain, B Pouillart, P

Citation: Jy. Pierga et al., Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer, BR J CANC, 83(11), 2000, pp. 1480-1487